1Vincenti F, Charpentier B, Vanrenterghem Y, et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant, 2010, 10(3) :535-546.
2Christie JD, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: twenty-eighth adult lung and heart-lung transplant report-2011[J]. J Heart Lung Transplant, 2011, 30(10) : 1104-1122.
3Stehlik J, Edwards LB, Kueheryavaya AY, et al. The registry of the international society for heart and lung transplantation: twenty-seventh official adult heart transplant report-2010[J]. J Heart Lung Transplant, 2010, 29(10):1089-1103.
4Christie JD, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation; twenty-seventh official adult lung and heart- lung transplant report--2010[J]. J Heart Lung Transplant, 2010, 29(10) : 1104-1118.
5Montgomery RA, Lonze BE, King KE, et al. Desensitization in HLA-incompatible kidney recipients and survival [J].N Engl J Med, 2011, 365(4) :318-326.
6Ott HC, Clippinger B, Conrad C, et al. Regeneration and orthotopic transplantation of a bioartificial lung[J]. Nat Med, 2010, 16(8) :927-933.
7Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation[J]. N Engl J Med, 2011, 364(15) : 1431-1440.
